COVID-19 antiviral pill could be ready by end of year, Pfizer CEO says

(By Maia Anderson for Becker’s Hospital Review)

An oral drug to treat COVID-19 at the first sign of illness, made by Pfizer, could be distributed across the U.S. by the end of the year, Pfizer CEO Albert Bourla, PhD, told CNBC April 27.  Continue reading the article here…

 

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply